PATENT CLAIM ANALYSIS

Application Number: 16036042
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "456000"]

Abstract:
Provided herein are methods of treating a subject having hepatitis B viral (HBV) infection. More specifically, disclosed herein are methods of stimulating the innate cytokine response in macrophages, dendritic cells and/or liver non-parenchymal cells with small molecular agonists of STING to suppress HBV replication in hepatocytes. The methods are especially suitable for use in the treatment of chronic HBV infections. Also disclosed herein are methods of identifying compounds useful in the treatment of HBV infection.

Claim (Index 3):
The method of  claim 1 , wherein the STING agonist stimulates an innate cytokine response in at least one cell in the subject, wherein the at least one cell is selected from the group consisting of macrophages, dendritic cells, liver non-parenchymal cells, and any combinations thereof.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 95.0
- Lexical Diversity: 1.53704
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15483645', '15028813', '15305180', '15898944', '14917958']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.805865913472121
- 35 USC 102 Novelty (BERT): 0.7141819199896156
- Combined Prediction Score: 0.7966975141238705
- Mean Citation Score: 482.01941199999993
- Max Citation Score: 753.25586
- Similarity Product: 747.2169602091502

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test